Regional Variation in the Use of Percutaneous Coronary Intervention in Japan

Takahiro Inoue; Hiroyo Kuwabara; Kiyohide Fushimi

首页> 外文期刊>Circulation journal >Regional Variation in the Use of Percutaneous Coronary Intervention in Japan

【24h】

Regional Variation in the Use of Percutaneous Coronary Intervention in Japan

机译：日本经皮冠状动脉干预使用的区域变异

获取原文

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Background: Regional variations in health-care delivery, processes and spending have been reported across the world. Differences in revascularization procedures have been observed in the USA and Canada, but little is known about regional variation in revascularization procedures in Japan.

机译：背景：在世界范围内报告了卫生保健，流程和支出的区域变化。在美国和加拿大已观察到血运重建程序的差异，但对日本血运重建程序的区域变异很少。

著录项

来源
《Circulation journal》 |2017年第2期|共4页
作者
Takahiro Inoue; Hiroyo Kuwabara; Kiyohide Fushimi;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类
关键词

相似文献

外文文献
中文文献
专利

1. Regional Variation in the Use of Percutaneous Coronary Intervention in Japan [J] . Inoue Takahiro, Kuwabara Hiroyo, Fushimi Kiyohide Circulation journal . 2017,第2期

机译：日本经皮冠状动脉干预使用的区域变异
2. Radial coronary interventions and post-procedural complication rates in the real world: A report from a Japanese multicenter percutaneous coronary intervention registry [J] . MizunoA., KohsakaS., MiyataH., International Journal of Cardiology . 2014,第1期

机译：real动脉冠状动脉介入治疗和现实世界中的术后并发症发生率：日本多中心经皮冠状动脉介入治疗注册表的报告
3. Regional and hospital variations in the extent of decline in the proportion of percutaneous coronary interventions performed for nonacute indications – a nationwide population-based study [J] . Fu-Wen Liang, Tsung-Hsueh Lu, Hsin-Min Wu, BMC Cardiovascular Disorders . 2017,第1期

机译：针对非急性适应症的经皮冠状动脉介入治疗的比例下降幅度方面的地区和医院差异–一项基于全国人群的研究
4. Influence of Diabetes Mellitus in patients with Long Coronary Lesions Undergoing Percutaneous Coronary Interventions: Multicenter PCI Registry in Japan [C] . E. Saito, M. Hirose, T. Miyauchi, International Congress on Coronary Artery Disease . 2003

机译：经皮冠状动脉干预患者糖尿病患者糖尿病的影响：日本多中心PCI登记处
5. The Association between Unfractionated Heparin and Bivalirudin Used during Percutaneous Coronary Intervention for Stable Angina and Acute Coronary Syndromes and the In-Hospital and Mortality Outcomes Observed across All Body Mass Index Groups [D] . Chen, Christine. 2021

机译：在所有体重指数群体中观察到稳定冠状动脉干预期间使用经皮冠状动脉介入和急性冠状动脉综合征的冠状动脉介入和医院和死亡率结果之间的联合肝素和Bivalirudin之间的关联
6. Original research article: Differences of in-hospital outcomes within patients undergoing percutaneous coronary intervention at institutions with high versus low procedural volume: a report from the Japanese multicentre percutaneous coronary intervention registry [O] . Masaki Kodaira, Toshiki Kuno, Yohei Numasawa, 2018

机译：原始研究文章：在程序量大或小的机构中经皮冠状动脉介入治疗患者的院内结局差异：日本多中心经皮冠状动脉介入治疗注册表的报告
7. The Relative Safety and Efficacy of Abciximab and Eptifibatide in Patients Undergoing Primary Percutaneous Coronary Intervention Insights From a Large Regional Registry of Contemporary Percutaneous Coronary Intervention [O] . Gurm Hitinder S., Smith Dean E., Collins J. Stewart, 2008

机译：从当代经皮冠状动脉介入治疗的大型区域登记中，接受阿昔单抗和依替非巴肽在接受主要经皮冠状动脉介入治疗的患者中的相对安全性和有效性

Regional Variation in the Use of Percutaneous Coronary Intervention in Japan

摘要

著录项

相似文献

相关主题

期刊订阅